CVS Health Co. (NYSE:CVS) Stake Cut by Clark Estates Inc. NY

Clark Estates Inc. NY lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 9.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,875 shares of the pharmacy operator’s stock after selling 3,800 shares during the quarter. Clark Estates Inc. NY’s holdings in CVS Health were worth $2,382,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Janus Henderson Group PLC raised its position in CVS Health by 2.5% during the first quarter. Janus Henderson Group PLC now owns 177,372 shares of the pharmacy operator’s stock valued at $14,143,000 after acquiring an additional 4,318 shares in the last quarter. New Covenant Trust Company N.A. acquired a new stake in shares of CVS Health in the first quarter worth about $241,000. Heartland Bank & Trust Co boosted its stake in shares of CVS Health by 124.9% during the 1st quarter. Heartland Bank & Trust Co now owns 8,196 shares of the pharmacy operator’s stock worth $654,000 after acquiring an additional 4,552 shares in the last quarter. Strategic Wealth Partners Ltd. increased its holdings in shares of CVS Health by 6.2% during the 1st quarter. Strategic Wealth Partners Ltd. now owns 61,939 shares of the pharmacy operator’s stock valued at $4,940,000 after acquiring an additional 3,628 shares during the last quarter. Finally, LRI Investments LLC bought a new position in shares of CVS Health in the first quarter valued at approximately $1,085,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 1.8 %

Shares of CVS opened at $59.02 on Wednesday. The business’s 50 day simple moving average is $59.26 and its 200-day simple moving average is $58.69. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25. The company has a market capitalization of $74.27 billion, a P/E ratio of 14.98, a PEG ratio of 1.01 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the prior year, the business earned $2.21 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, sell-side analysts predict that CVS Health Co. will post 5.43 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.51%. CVS Health’s payout ratio is 67.51%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent analyst reports. TD Cowen lifted their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday. Barclays dropped their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Mizuho cut their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $70.33.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.